KCG
VPHM

Knight Capital Group’s VIROPHARMA INC VPHM Stock Holding History

Knight Capital Group’s Portfolio VPHM Stock Details VPHM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q2 		$301K Buy
+10,521
New +$278K 0.01% 2234

Other funds holding VPHM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Knight Capital Group's VPHM Position: Q2 2013 in Review

Knight Capital Group opened a new position in VIROPHARMA INC (VPHM) in Q2 2013: 10,521 shares worth $301K. The stake represents 0.01% of the portfolio and ranks #2234 among its holdings.

174 funds tracked by Wall St. Rank hold VPHM as of Q2 2013.

  • Knight Capital Group held 10,521 shares of VIROPHARMA INC worth $301K as of Q2 2013.
  • VIROPHARMA INC was a new Knight Capital Group position in Q2 2013.
  • VIROPHARMA INC made up 0.01% of Knight Capital Group's portfolio in Q2 2013, its #2234 holding.
  • 174 funds tracked by Wall St. Rank held VIROPHARMA INC as of Q2 2013.

Based on Knight Capital Group's 13F filing for Q2 2013, filed 8 Aug 2013.